ClinicalTrials.Veeva

Menu

iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

Glaukos logo

Glaukos

Status

Terminated

Conditions

Primary Open Angle Glaucoma (POAG)

Treatments

Device: iStent inject surgery

Study type

Interventional

Funder types

Industry

Identifiers

NCT03478293
GCF-045

Details and patient eligibility

About

The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications.

Full description

The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications. Outcomes will be evaluated at 12 and 24 months.

Enrollment

6 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosed with primary open angle glaucoma (POAG)
  • Subject on two ocular hypotensive medications

Exclusion criteria

  • Traumatic, uveitic, neovascular, or angle closure glaucoma
  • Fellow eye already enrolled

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

6 participants in 1 patient group

iStent inject surgery
Experimental group
Description:
Single-arm study. Intervention is micro-invasive glaucoma surgery (MIGS) to implant iStent inject
Treatment:
Device: iStent inject surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems